ESC 365 - 2021 ESC/EACTS VHD guidelines: evolution of treatment recommendations.

Open Access

2021 ESC/EACTS VHD guidelines: evolution of treatment recommendations.

Session: The Future of TAVI: How are the new 2021 ESC/EACTS VHD guidelines changing management and treatment of patients with aortic stenosis

Topic: Aortic Valve Stenosis

Speaker: Professor J. Sinning (Cologne, DE)

Sponsored by Edwards Lifesciences

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Professor Jan-Malte Sinning

St. Vinzenz-Hospital, Cologne (Germany)

5 presentations

0 follower

5 more presentations in this session

Introduction purpose and learning objectives.

Speaker: Professor B. Prendergast (London, GB)

The future of TAVI treatment.

Speaker: Doctor F. Saia (Bologna, IT)

Panel discussion.

Round table:Newly eligible TAVI patients in 2021 - A case study on the benefit of holistic management.

Speaker: Professor J. Kempfert (Berlin, DE)

Wrap up with key learnings.

Speaker: Professor B. Prendergast (London, GB)

Access the full session

The Future of TAVI: How are the new 2021 ESC/EACTS VHD guidelines changing management and treatment of patients with aortic stenosis

Speakers: Professor J. Sinning, Professor B. Prendergast, Doctor F. Saia, Professor J. Kempfert, Professor B. Prendergast

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Related content

EHRA Premium Access

EHRA position paper on leadless pacing and extravascular defibrillators.

3 April 2022

ACVC Premium Access

The patient with acute myocarditis.

19 March 2022

ACVC Premium Access

Management of acute pericarditis refractory to first-line treatments.

19 March 2022

ESC 365 is supported by